611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...

Sexually Transmitted Diseases
Basic InformationLatest News
Researchers Move Toward Once-Yearly Treatment for HIVDon't Use Pricey New HIV PrEP Drug When Generics Available: StudySecond HIV Patient Reportedly 'Cured'Gay Men Underestimate Their Risks From HPVAnother HIV Hazard: Higher Risk for COPDAge Makes the Difference in Sticking With HIV MedsFew Teen Boys at Risk for HIV Get TestedHIV Drug Costs Soaring, Jeopardizing Effort to End EpidemicHIV Triggers Immune System 'Amnesia' to Smallpox: StudyHIV Testing, Treatment Not Reaching Many AmericansAn HIV Med Is Tied to Too-Small Heads in NewbornsAHA News: HIV Could Increase Risk of Death From Heart FailureStudies Confirm HPV Shot Is SafeNeedle Exchange Programs Guard Against HIVScientists ID Clue in Effort to Contain Herpes VirusHIV Could Speed Menopause Onset'Hey, What Is This?': Social Media, Not Docs, Increasingly Diagnosing STDsChlamydia Can Harm Male FertilitySTD Rates Continue to Rise in the U.S.Kidney Transplants Between People With HIV Are SuccessfulExperimental Genital Herpes Vaccine Shows Promise in MiceStudy Points to Herd Immunity Against HPV in Unvaccinated U.S. AdultsHaving HIV May Heighten Stroke RiskFor Kids Born With HIV, Taking Needed Meds Gets Harder With Age: StudyIs a Chlamydia Vaccine on the Horizon?Health Tip: Reducing Your Risk of HPVDual Therapy Might Be Advance Against Genital Herpes, Animal Study SuggestsHIV Lurking in Spinal Fluid Linked to Thinking ProblemsIn a First, Scientists Eliminate HIV From an Animal's GenomeMost Americans Have Never Had an HIV Test: CDCU.S. Expert Panel Supports HIV-Prevention Pill for People at High RiskHIV Patients More Likely to Have Heart Troubles, But Less Access to Care
Questions and AnswersLinksBook Reviews
Related Topics

Homosexuality & Bisexuality

Scientists ID Clue in Effort to Contain Herpes Virus

HealthDay News
by -- Robert Preidt
Updated: Nov 7th 2019

new article illustration

THURSDAY, Nov. 7, 2019 (HealthDay News) -- An inflammatory protein may play a part against the spread of sexually transmitted genital herpes virus in the nervous system, a new study says.

The findings could help lead to improved treatment of herpes, according to the researchers at the University of Arizona College of Medicine-Phoenix.

The protein, called IL-36y, was identified 20 years ago. Since then, research has shown that it plays an important role in chronic inflammatory diseases, but only recently have investigators started to examine its role in infectious diseases such as herpes.

After initial vaginal infection with genital herpes simplex virus 2 (HSV-2), the virus spreads through a woman's nervous system and goes into "hiding." It remains in hiding for a lifetime and periodically reactivates and causes lesions, the researchers explained.

"We were the first group to detect IL-36y in the female reproductive tract and have been extending this work to evaluate the extent that this molecule can protect against, or contribute to, genital infection," study senior author Melissa Herbst-Kralovetz said in a university news release. She's an associate professor of basic medical sciences.

Study leader Jameson Gardner said the researchers "really were excited to see that after intravaginal HSV-2 infection, the virus was able to spread systemically throughout the nervous system and to the brain in those lacking IL-36y."

He said the control group, which had the gene intact, was significantly more protected against HSV-2 spread in the nervous system.

Gardner is a graduate research student in the lab of Herbst-Kralovetz.

"We've shown that IL-36y appears to function in a previously uncharacterized manner to protect against virus neuroinvasion [an infection that affects the nervous system]," Gardner said in the release.

However, it's not yet known how IL-36y does this, the study authors said.

Despite the use of antiviral medications to treat genital herpes, more than 260 million women worldwide have the lifelong infection that can be transmitted to others, according to the authors.

Researchers have worked for decades to develop a vaccine to protect against genital herpes, but none has succeeded so far, Gardner said.

"Our understanding of how IL-36y functions can aid in the development of novel therapeutics to protect against -- and hopefully decrease -- the burden of [sexually transmitted infections] around the world," he added.

The findings are in the October issue of the Journal of Immunology.

More information

The American College of Obstetricians and Gynecologists has more on genital herpes.